Kimberly M Brown1, David A Geller2,3. 1. Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA. 2. Liver Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. gellerda@upmc.edu. 3. UPMC Liver Cancer Center, UPMC Montefiore, 3459 Fifth Ave, 7 South, Pittsburgh, PA, 15213-2582, USA. gellerda@upmc.edu.
Abstract
BACKGROUND: Laparoscopic liver resection is rapidly expanding with more than 9500 cases performed worldwide. While initial series reported non-anatomic resection of benign peripheral hepatic lesions, approximately 50-65 % of laparoscopic liver resections are now being done for malignant tumors, primarily hepatocellular carcinoma (HCC) or colorectal cancer liver metastases (mCRC). METHODS: We performed a literature review of published studies evaluating outcomes of major laparoscopic liver resection, defined as three or more Couinaud segments. RESULTS: Initial fears of adverse oncologic outcomes or tumor seeding have not been demonstrated, and dozens of studies have reported comparable 5-year disease-free and overall survival between laparoscopic and open resection of HCC or mCRC in case-cohort and propensity score-matched analyses. Increased experience has led to laparoscopic anatomic liver resections including laparoscopic major hepatectomy. A steep learning curve of 45-60 cases is evident for laparoscopic hepatic resection. CONCLUSION: Laparoscopic major hepatectomy is safe and effective in the treatment of benign and malignant liver tumors when performed in specialized centers with dedicated teams. Comparable to other complex laparoscopic surgeries, laparoscopic major hepatectomy has a learning curve of 45-60 cases.
BACKGROUND: Laparoscopic liver resection is rapidly expanding with more than 9500 cases performed worldwide. While initial series reported non-anatomic resection of benign peripheral hepatic lesions, approximately 50-65 % of laparoscopic liver resections are now being done for malignant tumors, primarily hepatocellular carcinoma (HCC) or colorectal cancer liver metastases (mCRC). METHODS: We performed a literature review of published studies evaluating outcomes of major laparoscopic liver resection, defined as three or more Couinaud segments. RESULTS: Initial fears of adverse oncologic outcomes or tumor seeding have not been demonstrated, and dozens of studies have reported comparable 5-year disease-free and overall survival between laparoscopic and open resection of HCC or mCRC in case-cohort and propensity score-matched analyses. Increased experience has led to laparoscopic anatomic liver resections including laparoscopic major hepatectomy. A steep learning curve of 45-60 cases is evident for laparoscopic hepatic resection. CONCLUSION: Laparoscopic major hepatectomy is safe and effective in the treatment of benign and malignant liver tumors when performed in specialized centers with dedicated teams. Comparable to other complex laparoscopic surgeries, laparoscopic major hepatectomy has a learning curve of 45-60 cases.
Authors: Murtaza Shakir; Brian A Boone; Patricio M Polanco; Mazen S Zenati; Melissa E Hogg; Allan Tsung; Haroon A Choudry; A James Moser; David L Bartlett; Herbert J Zeh; Amer H Zureikat Journal: HPB (Oxford) Date: 2015-04-23 Impact factor: 3.647
Authors: Christopher G Andrew; Wael Hanna; Didier Look; Alexander P H McLean; Nicolas V Christou Journal: Can J Surg Date: 2006-12 Impact factor: 2.089
Authors: Joseph F Buell; Daniel Cherqui; David A Geller; Nicholas O'Rourke; David Iannitti; Ibrahim Dagher; Alan J Koffron; Mark Thomas; Brice Gayet; Ho Seong Han; Go Wakabayashi; Giulio Belli; Hironori Kaneko; Chen-Guo Ker; Olivier Scatton; Alexis Laurent; Eddie K Abdalla; Prosanto Chaudhury; Erik Dutson; Clark Gamblin; Michael D'Angelica; David Nagorney; Giuliano Testa; Daniel Labow; Derrik Manas; Ronnie T Poon; Heidi Nelson; Robert Martin; Bryan Clary; Wright C Pinson; John Martinie; Jean-Nicolas Vauthey; Robert Goldstein; Sasan Roayaie; David Barlet; Joseph Espat; Michael Abecassis; Myrddin Rees; Yuman Fong; Kelly M McMasters; Christoph Broelsch; Ron Busuttil; Jacques Belghiti; Steven Strasberg; Ravi S Chari Journal: Ann Surg Date: 2009-11 Impact factor: 12.969
Authors: Ioannis A Ziogas; Alexandros P Evangeliou; Konstantinos S Mylonas; Dimitrios I Athanasiadis; Panagiotis Cherouveim; David A Geller; Richard D Schulick; Sophoclis P Alexopoulos; Georgios Tsoulfas Journal: Eur J Health Econ Date: 2021-03-19
Authors: Sean P Martin; Justin Drake; Michael M Wach; Samantha Ruff; Laurence P Diggs; Jim Y Wan; Zachary J Brown; Reed I Ayabe; Evan S Glazer; Paxton V Dickson; Jeremy L Davis; Jeremiah L Deneve; Jonathan M Hernandez Journal: Ann Surg Oncol Date: 2019-03-20 Impact factor: 5.344
Authors: Ser Yee Lee; Brian K P Goh; Gholami Sepideh; John C Allen; Ryan P Merkow; Jin Yao Teo; Deepa Chandra; Ye Xin Koh; Ek Khoon Tan; Juinn Haur Kam; Peng Chung Cheow; Pierce K H Chow; London L P J Ooi; Alexander Y F Chung; Michael I D'Angelica; William R Jarnagin; T Peter Kingham; Chung Yip Chan Journal: J Gastrointest Surg Date: 2018-11-12 Impact factor: 3.452
Authors: Ioannis A Ziogas; Dimitrios Giannis; Stepan M Esagian; Konstantinos P Economopoulos; Samer Tohme; David A Geller Journal: Surg Endosc Date: 2020-09-28 Impact factor: 4.584